Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Nov
1
2021
Spotlight on Upcoming Oral Arguments - November 2021 Finnegan
Oct
28
2021
Design Patent Claims Limited to Recited Article of Manufacture Finnegan
Oct
28
2021
This Case Is Both Hot and Exceptional—Attorneys’ Fees and Inequitable Conduct McDermott Will & Emery
Oct
26
2021
Federal Circuit Clarifies that Willful Infringement Does Not Require Egregious Conduct Mintz
Oct
21
2021
Means-Plus-Function Claims: Don’t Forget the “Way” McDermott Will & Emery
Oct
21
2021
NDA Forum Selection Clause Doesn’t Bar IPR in Response to Subsequent Infringement Suit McDermott Will & Emery
Oct
21
2021
PTO’s Financial Benefits from IPR Don’t Render PTAB Unconstitutional McDermott Will & Emery
Oct
21
2021
Update: Absent Explicit Statutory Language? The American Rule Still Applies McDermott Will & Emery
Oct
14
2021
Authentication Claim Under Alice—A Two-Step Process McDermott Will & Emery
Oct
14
2021
Design Patent Prior Art Must Be From Same or Analogous Field as Claimed Article of Manufacture McDermott Will & Emery
Oct
14
2021
Ex Parte Reexamination Not Allowed After Failed IPR Challenge McDermott Will & Emery
Oct
14
2021
Failing to Address All Reasons for Noninfringement Renders Appeal Moot McDermott Will & Emery
Oct
12
2021
Multiple, Serial IPR Filings Doom Reexamination Request Finnegan
Oct
11
2021
Federal Circuit Allows Service by Alternative Means Under Rule 4(f)(3) in Patent Cases Squire Patton Boggs (US) LLP
Oct
7
2021
Induced Infringement Finding May Support Willfulness Finding McDermott Will & Emery
Oct
7
2021
Federal Circuit to WD Tex.: Denial of Transfer Motion was Clear Error, Abuse of Discretion McDermott Will & Emery
Oct
1
2021
Federal Circuit Clarifies That There Is Not a Heightened Standard for Willful Infringement Finnegan
Oct
1
2021
Mind Your Jury Instructions and Get a Second Set of Eyes to Review Them before Your Counsel Submits Them to the Other Side of the Court Norris McLaughlin P.A.
Oct
1
2021
Federal Circuit PTAB Appeal Statistics Through August 31, 2021 Finnegan
Oct
1
2021
Bad Acts and Actors Never Die; They Simply Lose Their Appeal Finnegan
Sep
30
2021
One for All, and All for One . . . Except When It Comes to Patent License Comparability McDermott Will & Emery
Sep
30
2021
Spotlight on Upcoming Oral Arguments – October 2021 Finnegan
Sep
27
2021
Federal Circuit Crystallizes BMS’ Apixaban District Court Win Finnegan
Sep
24
2021
“You Got To Know When To Protest” Part III: The Court Of Federal Claims Declines To Expand Blue & Gold Waiver Rule For Bid Protests “Any Further Than The Federal Circuit Already Has” Sheppard, Mullin, Richter & Hampton LLP
Sep
23
2021
Discretion to Authorize Hague Alternative Service on Foreign Defendant—It’s All About Time and Cost McDermott Will & Emery
Sep
22
2021
Federal Circuit Denies Mandamus Petition, Confirming Non-Appealability of Institution Decisions Despite Parties’ Agreement to First Arbitrate Patent Validity Finnegan
Sep
21
2021
The Federal Circuit Awards New Trial on Damages Finnegan
Sep
20
2021
Testing the Limits of Therasense: Patent Owner’s Decision Not to Appeal Obviousness Holding Created But-for Materiality and Knowledge of Withheld References Established Intent Finnegan
Sep
17
2021
A Trademark by Any Other Name: Why the UGG Brand Left Some Australians Saying “Ugh” Norris McLaughlin P.A.
Sep
16
2021
Federal Circuit: Contractual Arbitration Agreements Don’t Bind PTAB Institution Decisions McDermott Will & Emery
Sep
16
2021
Genus Claims: Foiled Again by Written Description Mintz
Sep
16
2021
Notice Under § 287 Means Knowledge of Infringement, Not Knowledge of Patent McDermott Will & Emery
Sep
16
2021
TTAB Judicial Appointments are Determined Constitutionally Sound McDermott Will & Emery
Sep
16
2021
Material Information Submitted to FDA but Withheld from PTO Gives Rise to Inequitable Conduct McDermott Will & Emery
Sep
9
2021
Federal Circuit Reiterates Requirement under § 287 that Alleged Infringers have Notice of Specific Alleged Infringement Mintz
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters